Original research and analysis on rare disease, metabolic health, and the biology of ageing. By Dima Martini-Drew MD, physician-scientist and founder of CortexBio.

Contributors

C

Christopher Drew

Physician-Scientist and Strategist in Metabolism of Ageing and Rare Disease. 30 years in drug development across Astellas, Abbott, and Genzyme. Biotech Trailblazers 2025. Founder, CortexBio®.